[TRVI] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[TRVI] Trevi Therapeutics, Inc.
Announcement Date
20-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -1.60%
YoY- -42.10%
Quarter Report
TRVI's Result
TRVI's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 176 0 0 0 0 0 0 -
PBT -7,803 -5,524 -8,526 -9,506 -6,541 -6,031 -2,386 21.82%
Tax 18 -20 -6 17 -4 -49 8 14.46%
NP -7,821 -5,504 -8,520 -9,523 -6,537 -5,982 -3,485 14.41%
Tax Rate - - - - - - - -
Total Cost 7,997 5,504 8,520 9,523 6,537 5,982 3,485 14.84%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -4,443.75 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.08 -0.06 -0.39 -0.51 -0.37 -0.34 -8.05 -53.61%
EPS Diluted -0.08 -0.06 -0.39 -0.51 -0.37 -0.34 -8.05 -53.61%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.